Granules India Limited Buyback 2020
(i) It is a Pharma company. They have a strong presence in the ‘first line of defense’ products, including Paracetamol, Ibuprofen, Guaifenesin, and Metformin. They export nearly 60% of its revenue to the US and Europe.
(ii) The key customers include some of the leading generic, as well as, branded pharmaceutical companies.
(iii) They have emerged into a knowledge-driven, R&D focused, multi-product organization, with inherent strength in the efficient manufacturing of high-volume pharmaceutical products.
Buy Back Offer Deal:
|Buyback Type:||Tender Offer|
|Buyback Record Date:||Mar 20 2020|
|Buyback Opening Date:||Jun 08 2020|
|Buyback Closing Date:||Jun 19 2020|
|Buyback Offer Amount:||₹ 250 Crores|
|Date of Board Meeting approving the proposal:||Jan 21 2020|
|Date of Public Announcement:||Jan 21 2020|
|Buyback Offer Size:||4.92%|
|Buyback Number of Shares:||1,25,00,000|
|Price Type:||Tender Offer|
|Buyback Price:||₹ 200 Per Equity Share|
Details of Buyback:
Salient financial parameters:
How to Participate in buyback?
Profit from the buyback on the bases of acceptance Ratio:
|Amount Invested in Buyback||1,38,000||1,38,000||1,38,000||1,38,000|
|No. of Shares buyback||330||500||750||1000|